Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EUROFINS BIOPHARMA PRODUCT TESTING NORWAY AS
AS
Active
Org 931468065
Møllebakken 40, 1538
Moss
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2023
1 employees
Watchlist
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
EUROFINS BIOPHARMA PRODUCT TESTING NORWAY AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JR
Jan Rando
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
SA
Svend Aage Linde
Chairman
2023
JR
Jon Ragnar Røed
Board of Directors
2023
MS
Mersiha Strmonja Kenjar
Board of Directors
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Eurofins Biopharma Product Testing
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on EUROFINS BIOPHARMA PRODUCT TESTING NORWAY AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
